KYMR
Kymera Therapeutics, Inc.
Stock
$107.39−2.73 (−2.48%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$233M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$233M | — |
| 2024 | −$195M | — |
| 2023 | −$103M | — |
| 2022 | −$153M | — |
| 2021 | −$129M | — |
| 2020 | $88M | +392.2% |
| 2019 | $18M | — |